结核病与肺部健康杂志 ›› 2019, Vol. 8 ›› Issue (2): 111-114.doi: 10.3969/j.issn.2095-3755.2019.02.008

• 论著 • 上一篇    下一篇

2016—2018年北京市昌平区MTB分离株对氧氟沙星耐药情况分析

王燕飞1,吴进凤2(),孙倩2,韩露2,马树波2,张治国2   

  1. 1. 102212 北京市昌平区兴寿镇社区卫生服务中心
    2. 北京市昌平区结核病防治所
  • 收稿日期:2019-06-10 出版日期:2019-06-30 发布日期:2019-07-10
  • 基金资助:
    国家科技重大专项(2018ZX10103001);首都卫生发展科研专项(2018-1-1041)

Ofloxacin-resistant characteristics of Mycobacterium tuberculosis isolated from Changping District in Beijing during 2016-2018

Yan-fei WANG1,Jin-feng WU2(),Qian SUN2,Lu HAN2,Shu-bo MA2,Zhi-guo ZHANG2   

  1. 1. Xingshou Community Health Service Center, Changping District, Beijing 102212, China
  • Received:2019-06-10 Online:2019-06-30 Published:2019-07-10

摘要:

目的 分析北京市昌平区MTB对氧氟沙星耐药的情况,以便为临床防治耐药结核病提供参考。方法 本研究搜集2016—2018年昌平区结核病防治机构701株MTB临床分离株,采用比例法药物敏感性试验(简称“药敏试验”)检测其耐药性,耐多药MTB 51株,非耐多药MTB 650株。同时对氧氟沙星耐药菌株的gyrA基因进行测序分析。统计各年MTB对氧氟沙星的耐药率,各年间耐药率的比较采用 χ 趋势 2 检验,以P<0.05为差异有统计学意义。 结果 701株MTB临床分离菌株中,对氧氟沙星耐药者41株,耐药率为5.8%。3年中MTB对氧氟沙星的耐药率呈显著增长,2016年耐药率为2.9%(7/243),2017年为6.9%(16/232),2018年为8.0%(18/226), χ 趋势 2 =5.567,P=0.018。耐多药和非耐多药结核分枝杆菌对氧氟沙星耐药率分别为37.2%(19/51)和3.4%(22/650),耐多药 MTB对氧氟沙星的耐药率显著高于非耐多药 MTB(χ 2=92.462,P<0.01)。在41株对氧氟沙星耐药的MTB菌株中,总计有31株(75.6%)检测到gyrA基因突变。其中最常见的突变在94位密码子(15株,36.6%)和90位点(14株,34.1%)。结论 北京市昌平区MTB临床分离菌株对氧氟沙星的耐药率2016—2018年呈逐年上升的趋势,gyrA基因突变是本区MTB菌株对氧氟沙星耐药的最主要的耐药机制。

关键词: 分枝杆菌, 结核, 氧氟沙星, 抗药性, 微生物敏感性试验, DNA突变分析, 数据说明, 统计, 小地区分析

Abstract:

Objective To investigate the prevalence and molecular characteristics of Ofloxacin (Ofx)-resis-tant Mycobacterium tuberculosis (MTB) isolates from Changping District of Beijing, so as to provide reference for clinical prevention and treatment of drug-resistant tuberculosis.Methods Seven hundred and one strains of MTB clinical isolates in Changping Tuberculosis Dispensary were collected from 2016 to 2018. Conventional proportional method (referred to as “drug sensitivity test”, DST) was used to detect in vitro drug susceptibility of MTB isolates. Among those clinical isolates, 51 strains were detected as multi-drug resistant(MDR)MTB, 650 strains were not MDR. GyrA gene mutations of Ofx-resistant isolates were test by gene sequencing. The resistance rates of Ofx in each year were compared using Cochran-Armitage trend test. The difference was significant if P<0.05.Results Of 701 MTB isolates, 41 (5.8%) were resistant to Ofx. Statistical analysis revealed that the resistance rate of Ofx was significantly increased from 2.9% (7/243) in 2016 to 8.0% (18/226) in 2018 ( χ trend 2 =5.567, P=0.018). In addition, the Ofx resistant rates were 37.2% (19/51) and 3.4% (22/650) in MDR and non-MDR clinical MTB isolates, respectively, with significant difference (χ 2=92.462, P<0.01). GyrA gene mutation was detected in 31 strains (75.6%) of 41 Ofx resistant MTB strains. The most common mutations were 94 codons (36.6%) and 90 loci (34.1%).Conclusion The Ofx resistant rate of the clinical isolates of MTB in Changping District shows an increasing trend from 2016 to 2018. The mutation of GyrA gene is the most predominant mechanism associated with Ofx resistance in this region.

Key words: Mycobacterium, tuberculosis, Ofloxacin, Drug resistance, Microbial sensitivity tests, DNA mutational analysis, Data interpretation, statistical, Small-area analysis